fingolimod hydrochloride has been researched along with pramipexole in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 1,103 | 219 | 517 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boguszewski, PM; Kosson, P; Motyl, J; Przykaza, Ł; Strosznajder, JB | 1 |
1 other study(ies) available for fingolimod hydrochloride and pramipexole
Article | Year |
---|---|
Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; bcl-Associated Death Protein; Brain; Fingolimod Hydrochloride; Male; Mice; MPTP Poisoning; Neuroprotection; Parkinson Disease; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Pramipexole; Proto-Oncogene Proteins c-akt; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2018 |